Arvinas reports Q4/FY2025 cash of $685.4M, appoints new CEO Randy Teel, PDUFA date June 2026

ARVINAS, INC.

2025-FY EPS reported -$1.14 vs consensus -$0.60 ▼ miss (-89.3%)

Cash and equivalents $685.4M at Dec 31, 2025 (vs $1,039.4M in 2024); runway into 2H 2028.
GAAP R&D expenses $285.2M for FY2025, down from $348.2M in FY2024.
Randy Teel, Ph.D., appointed President, CEO, and Director; John Houston retired but remains on Board.
First NDA submitted for vepdegestrant (PROTAC ER degrader); PDUFA action date June 5, 2026.
Repurchased $91.9M of common stock under buyback program in FY2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.